Avaxim 160 Unit (Hepatitis a Virus, Inactivated SUSPENSION) 160 UNIT

AVAXIM 160 Unit is a hepatitis A vaccine designed to protect against hepatitis A virus infection. This inactivated vaccine is administered intramuscularly and is suitable for individuals seeking immunity.

Strength

160 UNIT

Pack Size

0.5ML SYRINGE

Manufacturer / TM Owner

SANOFI PASTEUR LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AVAXIM 160 Unit is used to prevent hepatitis A, a viral infection that can cause liver inflammation. It is typically recommended for individuals traveling to regions with high hepatitis A prevalence or those at increased risk of exposure. The vaccine works by stimulating the body's immune response to develop protection against the virus.

Side Effects

Common effects of AVAXIM 160 Unit may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or low-grade fever. These effects are generally mild and short-lived.

Precautions & Warnings

AVAXIM 160 Unit should be stored as directed to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Individuals with severe allergies to vaccine components should avoid this product.

Avoid Interactions

AVAXIM 160 Unit may interact with certain medications or other vaccines. It is advisable to discuss current medications with a healthcare provider before receiving the vaccine. Alcohol and other immune-suppressing substances might affect the vaccine's effectiveness.

Frequently Asked Questions

AVAXIM 160 Unit is used to prevent hepatitis A virus infection, particularly in individuals at risk or traveling to high-prevalence areas.

AVAXIM 160 Unit is administered intramuscularly, typically in the upper arm.

Common side effects include mild soreness, redness, or swelling at the injection site, as well as temporary fatigue or headache.

It is important to consult a healthcare provider about current medications before receiving AVAXIM 160 Unit to avoid potential interactions.

Individuals with severe allergies to vaccine components or those with certain medical conditions should avoid AVAXIM 160 Unit.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.